Association between the remnant cholesterol to high-density lipoprotein cholesterol ratio and the risk of coronary artery disease

被引:1
|
作者
Pan, Liting [1 ]
Jiang, Weifang [1 ]
Liao, Liping [1 ]
Li, Weizhen [1 ]
Wang, Fang [2 ,3 ]
机构
[1] Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Sch Med, Dept Neurol,Jiading Branch, Shanghai, Peoples R China
[2] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Cardiol, Shanghai, Peoples R China
[3] Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Cardiol, Sch Med, 197,Ruijin 2nd Rd, Shanghai 200025, Peoples R China
关键词
coronary artery disease; MACE; remnant cholesterol to high-density lipoprotein cholesterol ratio; TRIGLYCERIDES;
D O I
10.1097/MCA.0000000000001320
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The purpose of this study was to evaluate the relationship between remnant cholesterol (RC) to high-density lipoprotein cholesterol (HDL-C) ratio and the risk of coronary artery disease (CAD). We also investigated the clinical value of RC/HDL-C ratio in evaluating the severity of CAD and in predicting the short-term prognosis of CAD patients. Methods In total, 615 patients were enrolled and they were classified into a CAD group (418 cases) and a normal group (197 cases) according to the results of coronary angiography. Serum RC/HDL-C ratio and Gensini score were calculated. Multivariate logistic regression and receiver operating characteristic (ROC) curves were employed to evaluate the association between RC/HDL-C ratio and CAD. The effect of RC/HDL-C ratio on the progression of major adverse cardiovascular events (MACEs) was also explored. Results Increased RC/HDL-C ratio was associated with an increased risk of CAD (OR: 11.122; 95% CI: 5.90320.954; P < 0.001). When stratified by CAD subtypes, increased RC/HDL-C ratio was correlated with a greater risk of acute coronary syndrome (ACS) (OR:1.549; 95% CI: 1.0142.364; P < 0.05). Compared with the first quartile, the 4th quartile of RC/HDL-C ratio had a 9.774-fold (P = 0.000) increase in the odds ratio for CAD, and a 2.241-fold (P = 0.017) increase in the odds ratio for ACS. RC/HDL-C ratio was an independent determinant of Gensini score >= 32 (OR: 2.138, 95% CI:1.3893.292, P < 0.01), and multi-branch (MVD) (OR: 2.245; 95% CI: 1.4683.443; P < 0.001). The prevalence of Gensini score >= 32 and MVD in the 4th quartile of RC/HDL-C ratio group were much higher than that of other quartile groups (P < 0.01). Moreover, the areas under the ROC for the predictive value of RC/HDL-C ratio for CAD, ACS, Gensini score =32, and MVD were 0.702, 0.563, 0.602, and 0.669, respectively. Furthermore, the incidence of MACEs was significantly increased in CAD patients with levels of RC/HDL-C ratio (P < 0.05). Conclusion RC/HDL-C ratio plays an important role in the progression and severity of CAD.
引用
收藏
页码:114 / 121
页数:8
相关论文
共 50 条
  • [21] The association of cholesteryl ester transfer protein polymorphism with high-density lipoprotein cholesterol and coronary artery disease in Koreans
    Park, KW
    Choi, JH
    Kim, HK
    Oh, S
    Chae, IH
    Kim, HS
    Oh, BH
    Lee, MM
    Park, YB
    Choi, YS
    CLINICAL GENETICS, 2003, 63 (01) : 31 - 38
  • [22] Association between the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and cardiovascular outcomes in patients undergoing percutaneous coronary intervention: a retrospective study
    Liu, Jiuling
    Oorloff, Melysze Deanne
    Nadella, Adithya
    Guo, Ping
    Ye, Min
    Wang, Xiaoqing
    Zhao, Hang
    LIPIDS IN HEALTH AND DISEASE, 2024, 23 (01)
  • [23] Association of ratios of monocyte/high-density lipoprotein cholesterol and neutrophil/high-density lipoprotein cholesterol with atherosclerotic plaque type on coronary computed tomography
    Okan, Taha
    Topaloglu, Caner
    CARDIOVASCULAR JOURNAL OF AFRICA, 2024,
  • [24] The Association of Triglyceride to High-Density Lipoprotein Cholesterol Ratio with High-Risk Coronary Plaque Characteristics Determined by CT Angiography and Its Risk of Coronary Heart Disease
    Koide, Yuji
    Miyoshi, Toru
    Nishihara, Takahiro
    Nakashima, Mitsutaka
    Ichikawa, Keishi
    Miki, Takashi
    Osawa, Kazuhiro
    Ito, Hiroshi
    JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 2022, 9 (10)
  • [25] Relationship between high-density lipoprotein cholesterol and the red cell distribution width in patients with coronary artery disease
    Avci, Eyup
    Kiris, Tuncay
    Demirtas, Abdullah Orhan
    Kadi, Hasan
    LIPIDS IN HEALTH AND DISEASE, 2018, 17
  • [26] Relationship between high-density lipoprotein cholesterol and the red cell distribution width in patients with coronary artery disease
    Eyup Avci
    Tuncay Kiris
    Abdullah Orhan Demirtas
    Hasan Kadi
    Lipids in Health and Disease, 17
  • [27] Effects of Low-density Lipoprotein Cholesterol on Coronary Artery Calcification Progression According to High-density Lipoprotein Cholesterol Levels
    Lee, Da Young
    Kim, Ji Hyun
    Park, Se Eun
    Park, Cheol-young
    Oh, Ki-won
    Park, Sung-woo
    Rhee, Eun-Jung
    Lee, Won-young
    ARCHIVES OF MEDICAL RESEARCH, 2017, 48 (03) : 284 - 291
  • [28] Influence of high-density lipoprotein cholesterol on coronary collateral formation in a population with significant coronary artery disease
    Hsu P.-C.
    Su H.-M.
    Juo S.-H.
    Yen H.-W.
    Voon W.-C.
    Lai W.-T.
    Sheu S.-H.
    Lin T.-H.
    BMC Research Notes, 6 (1)
  • [29] High-Density Lipoprotein Cholesterol Efflux Capacity as a Novel Prognostic Surrogate for Coronary Artery Disease
    Hisauchi, Itaru
    Ishikawa, Tetsuya
    Ayaori, Makoto
    Uto-Kondo, Harumi
    Koshikawa, Yuri
    Ukaji, Tomoaki
    Nakamura, Hidehiko
    Mizutani, Yukiko
    Taguchi, Isao
    Nakajima, Takatomo
    Mutoh, Makoto
    Ikewaki, Katsunori
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2021, 28 (07) : 696 - 702
  • [30] Association of Increased Remnant Cholesterol and the Risk of Coronary Artery Disease: A Retrospective Study
    Wang Kexin
    Ding Yaodong
    Gao Wen
    Wang Rui
    Yang Jiaxin
    Liu Xiaoli
    Shen Hua
    Ge Hailong
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8